Genda-Bio

Brand Logo

Genda-Bio develops peptide-based nucleic acid delivery products for primary cells and other hard-to-transfect cell types. Its GentleFect platform uses a non-viral and non-lipid delivery approach designed for applications where conventional chemical transfection may provide low efficiency or poor cell viability.

The portfolio covers research-grade transfection reagents, cell therapy process-development products, messenger RNA, circular RNA, custom nucleic acid services and basic cell culture media.

GentleFect Nucleic Acid Delivery Platform

GentleFect uses engineered peptides that self-assemble with nucleic acids to form delivery complexes. The platform is designed to introduce nucleic acid cargo into primary cells while preserving cell viability.

Supported nucleic acid formats include:

  • Plasmid DNA
  • Messenger RNA
  • Small interfering RNA
  • Circular RNA
  • CRISPR-related components
  • Other experimental nucleic acids

The workflow does not require an electroporation instrument, making it potentially useful for laboratories seeking a chemical transfection method for primary cells.

Performance still depends on the target cell, nucleic acid quality, cargo size, cell density and culture conditions.

Primary T Cell Transfection

Gentle T30 is developed for nucleic acid delivery into primary T cells.

Applications include:

  • CAR construct delivery
  • TCR engineering
  • Reporter gene expression
  • CRISPR gene editing
  • Gene knockdown
  • Transient protein expression
  • Functional T cell studies
  • Cell therapy research

The product is available in several package sizes, allowing researchers to move from initial testing to larger experimental workflows.

Cell activation status can influence transfection performance. Researchers should evaluate transfection efficiency together with cell viability, expansion capacity and phenotype.

Primary NK Cell Transfection

Gentle NK30 is designed for primary NK cells, which are often difficult to transfect with standard lipid-based reagents.

Potential applications include:

  • CAR-NK research
  • mRNA delivery
  • Gene editing
  • Reporter expression
  • Gene regulation studies
  • Functional NK cell analysis
  • Cell therapy process development

Because NK cells can be sensitive to both transfection and handling, post-transfection viability and cytotoxic function should be assessed alongside delivery efficiency.

Other Primary and Difficult-to-Transfect Cells

The GentleFect product family also includes:

  • Gentle A30 for hard-to-transfect cell lines
  • Gentle AP30 for primary cells
  • Gentle S30 for primary stem cells
  • Gentle F30 for primary skin cells

Reagent selection should be based on the exact cell population. A general primary-cell reagent may not perform identically to a product optimized for T cells, NK cells or stem cells.

Nucleic Acid Products

Genda-Bio supplies ready-to-use nucleic acid products and custom synthesis services.

Available products include:

  • eGFP mRNA
  • mCherry mRNA
  • Luciferase mRNA
  • Cas9 mRNA
  • eGFP circular RNA
  • Custom mRNA synthesis

Reporter mRNA can be used as a positive control when establishing a new delivery protocol before testing a more complex experimental construct.

Cell Culture Media

The Genda-Bio catalog also includes high-glucose DMEM, low-glucose DMEM and sterile PBS for routine cell culture workflows.

These products complement the company’s transfection portfolio but should be selected according to the requirements of the target cell and experiment.

Research and Process-Development Applications

Genda-Bio products can support:

  • Primary cell transfection
  • T cell engineering
  • NK cell engineering
  • Stem cell transfection
  • CRISPR gene editing
  • mRNA delivery
  • siRNA knockdown
  • Circular RNA research
  • Cell therapy development
  • Gene function studies

Products Biolterna Can Help Source

Biolterna can assist with sourcing Gentle T30 Transfection Reagent for Primary T Cells, Gentle NK30 Transfection Reagent for Primary NK Cells and other GentleFect products.

When requesting a suitable reagent, provide the cell type, nucleic acid format, approximate cargo size, culture conditions and required experimental scale.

Research-grade and process-development products should be distinguished from materials manufactured for regulated cell therapy workflows.

Official website link:

Related Products

Genda-Bio Gentle NK30 transfection reagent for primary NK cells
Genda-Bio Gentle T30 peptide-based transfection reagent for primary T cells